J&J to spin off consumer products and focus on pharmaceuticals
Johnson & Johnson plans to spin off its consumer health division to focus on pharmaceuticals and medical devices in the biggest shake-up in the U.S. company’s 135-year history. The company said it was aiming to complete the separation in 18 to 24 months at a cost of $500 million to $1 billion. J&J shares, part…

